tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Acne Vulgaris D000152 35 associated lipids
Urination Disorders D014555 9 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Anemia, Hemolytic D000743 4 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Vision Disorders D014786 10 associated lipids
Multiple Myeloma D009101 13 associated lipids
Osteochondrodysplasias D010009 3 associated lipids
Melanoma D008545 69 associated lipids
Hematologic Diseases D006402 3 associated lipids
Muscular Dystrophies D009136 10 associated lipids
Osteoporosis D010024 12 associated lipids
Anemia, Aplastic D000741 6 associated lipids
Kidney Diseases D007674 29 associated lipids
Hematuria D006417 13 associated lipids
Weight Gain D015430 101 associated lipids
Brain Diseases D001927 27 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Jordan ML et al. FK 506 salvage of renal allografts with ongoing rejection failing cyclosporine immunosuppression. 1993 Transplant. Proc. pmid:7679827
Klintmalm GB et al. Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. 1993 Transplant. Proc. pmid:7679828
Lane BC et al. Evaluation of calcineurin's role in the immunosuppressive activity of FK 506, related macrolactams, and cyclosporine. 1993 Transplant. Proc. pmid:7679829
Celli S et al. Long-term survival of heart and liver xenografts with splenectomy and FK 506. 1993 Transplant. Proc. pmid:7679830
Japanese study of FK 506 on kidney transplantation: results of late phase II study. 1993 Transplant. Proc. pmid:7679831
Kobayashi M et al. Production of monoclonal antibody against recombinant human FKBP-12 and subcellular localization of FKBP-12 in human mononuclear and polymorphonuclear cells. 1993 Transplant. Proc. pmid:7679832
Kuroki H et al. Effect of FK 506 and donor-specific blood transfusion on the rat composite tissue limb allograft and the mechanism of long-term graft survival. 1993 Transplant. Proc. pmid:7679833
Azhderian EM et al. Nucleus associated FK 506 binding proteins with potential relevance to FK 506 immunosuppression. 1993 Transplant. Proc. pmid:7679834
Porayko MK et al. Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients. 1993 Transplant. Proc. pmid:7679835
Hirao A et al. Effects of immunosuppressants, FK506, deoxyspergualin, and cyclosporine A on immature human hematopoiesis. 1993 Blood pmid:7680241
Tamura K et al. Suppression of autoimmune thyroid disease by FK 506: influence on thyroid-infiltrating cells, adhesion molecule expression and anti-thyroglobulin antibody production. 1993 Clin. Exp. Immunol. pmid:7680293
Armitage JM et al. A decade (1982 to 1992) of pediatric cardiac transplantation and the impact of FK 506 immunosuppression. 1993 J. Thorac. Cardiovasc. Surg. pmid:7680396
Randhawa PS et al. The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine. 1993 Am. J. Surg. Pathol. pmid:7680544
Xu RX et al. Heteronuclear 3D NMR studies of water bound to an FK506 binding protein/immunosuppressant complex. 1993 Biochemistry pmid:7680570
Egan DA et al. Equilibrium denaturation of recombinant human FK binding protein in urea. 1993 Biochemistry pmid:7680574
Lionetti P et al. Activation of mucosal V beta 3+ T cells and tissue damage in human small intestine by the bacterial superantigen, Staphylococcus aureus enterotoxin B. 1993 Eur. J. Immunol. pmid:7680613
Nelson PA et al. Immunosuppressive activity of [MeBm2t]1-, D-diaminobutyryl-8-, and D-diaminopropyl-8-cyclosporin analogues correlates with inhibition of calcineurin phosphatase activity. 1993 J. Immunol. pmid:7680683
Piekoszewski W and Jusko WJ Plasma protein binding of tacrolimus in humans. 1993 J Pharm Sci pmid:7680714
Ning YM and Sánchez ER Potentiation of glucocorticoid receptor-mediated gene expression by the immunophilin ligands FK506 and rapamycin. 1993 J. Biol. Chem. pmid:7681058
López-Gil JA and García Sáiz M [FK506: an immunosuppressor for the '90's?]. 1993 Med Clin (Barc) pmid:7505871
Kagayama A et al. Oral absorption of FK506 in rats. 1993 Pharm. Res. pmid:7505939
Kim YI et al. Augmentation of hepatocyte proliferation by immunosuppressant pretherapy is associated with up-regulation of malondialdehyde production. 1993 Res Exp Med (Berl) pmid:7506444
Hytiroglou P et al. FK506 versus cyclosporine as primary immunosuppressive agent for orthotopic liver allograft recipients. Histologic and immunopathologic observations. 1993 Transplantation pmid:7506452
Hutchison KA et al. FK506 binding to the 56-kilodalton immunophilin (Hsp56) in the glucocorticoid receptor heterocomplex has no effect on receptor folding or function. 1993 Biochemistry pmid:7682438
Ishizuka J et al. Effects of FK506 and cyclosporine on dynamic insulin secretion from isolated dog pancreatic islets. 1993 Transplantation pmid:7506454
Shorrock C and Neuberger J The changing face of liver transplantation. 1993 Gut pmid:7682532
Dhar DK et al. Effective prevention of ischemic injury of the dearterialized canine liver by FK506 pretreatment. 1993 Transplantation pmid:7506456
Nakajima J [The immunosuppressive effects of FK506 on single lung allotransplantation in Japanese monkey (Macaca fuscata)]. 1993 Nihon Kyobu Geka Gakkai Zasshi pmid:7690829
Fabrega AJ et al. Enhancement of allograft survival by single intraoperative donor-specific blood transfusion combined with FK506. 1993 Transplantation pmid:7506458
Wenzel-Seifert K and Seifert R Partial inhibition of human neutrophil activation by FK-506 at supratherapeutic concentrations. 1993 Naunyn Schmiedebergs Arch. Pharmacol. pmid:7690907
Jain A et al. FK506 and pregnancy in liver transplant patients. 1993 Transplantation pmid:7506459
Liu J FK506 and cyclosporin, molecular probes for studying intracellular signal transduction. 1993 Immunol. Today pmid:7691065
Winkler ME et al. Successful pregnancy in a patient after liver transplantation maintained on FK 506. 1993 Transplantation pmid:7506460
Mori T et al. FK-506: a new immunosuppressive agent, failed to reduce cerebral vasospasm after experimental subarachnoid hemorrhage. 1993 J. Vet. Med. Sci. pmid:7691190
Yoshizawa K et al. Establishment of Epstein-Barr virus-associated lymphoma cell line SUBL with t(2;3)(p11;q27) from a liver transplant patient. 1993 Cancer Genet. Cytogenet. pmid:7506636
Distant DA and Gonwa TA The kidney in liver transplantation. 1993 J. Am. Soc. Nephrol. pmid:7691205
Muthukkumar S et al. Elevation of cytosolic calcium is sufficient to induce growth inhibition in a B cell lymphoma. 1993 Eur. J. Immunol. pmid:7691606
Wesselborg S et al. Triggering via the alternative CD2 pathway induces apoptosis in activated human T lymphocytes. 1993 Eur. J. Immunol. pmid:7691614
Schulz BS et al. Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro. 1993 J. Immunol. pmid:7691948
Iwasaki K et al. Effects of twenty-three drugs on the metabolism of FK506 by human liver microsomes. 1993 Res. Commun. Chem. Pathol. Pharmacol. pmid:7508138
Takada K et al. Distribution characteristics of immunosuppressants FK506 and cyclosporin A in the blood compartment. 1993 Biopharm Drug Dispos pmid:7508273
Smith DF et al. FKBP54, a novel FK506-binding protein in avian progesterone receptor complexes and HeLa extracts. 1993 J. Biol. Chem. pmid:7693698
Thomson AW et al. Comparative effects of rapamycin, FK 506 and cyclosporine on antibody production, lymphocyte populations and immunoglobulin isotype switching in the rat. 1993 Immunopharmacol Immunotoxicol pmid:7693791
Sperr WR et al. [Effector cells in allergy: biological principles and new pharmacologic concepts]. 1993 Wien. Klin. Wochenschr. pmid:7508662
Tzakis AG et al. Intestinal transplantation in children under FK 506 immunosuppression. 1993 J. Pediatr. Surg. pmid:7693907
Kawauchi M et al. Prolonged survival of orthotopically transplanted heart xenograft in infant baboons. 1993 J. Thorac. Cardiovasc. Surg. pmid:7693999
Shutter LA et al. Cortical blindness and white matter lesions in a patient receiving FK506 after liver transplantation. 1993 Neurology pmid:7694189
Dawson TM et al. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. 1993 Proc. Natl. Acad. Sci. U.S.A. pmid:7694293
Spencer DM et al. Controlling signal transduction with synthetic ligands. 1993 Science pmid:7694365
Travis J Making molecular matches in the cell. 1993 Science pmid:7694368
Jusko WJ and Kobayashi M Therapeutic monitoring of tacrolimus (FK 506) 1993 Ther Drug Monit pmid:7694395
Kunz J and Hall MN Cyclosporin A, FK506 and rapamycin: more than just immunosuppression. 1993 Trends Biochem. Sci. pmid:7694398
McMichael J et al. Computer-guided concentration-controlled trials in autoimmune disorders. 1993 Ther Drug Monit pmid:7510078
Lemster B et al. Blood lymphocytes of autoimmune disease patients receiving FK506 exhibit normal ex vivo cytokine gene expression and proliferative responses. 1993 Immunol. Lett. pmid:7510265
Parent SA et al. Calcineurin-dependent growth of an FK506- and CsA-hypersensitive mutant of Saccharomyces cerevisiae. 1993 J. Gen. Microbiol. pmid:7510323
Asami M et al. Detection of the FK506-FKBP-calcineurin complex by a simple binding assay. 1993 Biochem. Biophys. Res. Commun. pmid:7685169
Metcalfe S et al. Prodigiosin 25C: effect in in vitro models for T cell activation and T cell cycling and in vivo for rat heart allografts. 1993 Int. Arch. Allergy Immunol. pmid:7685216
Bumgardner GL and Roberts JP New immunosuppressive agents. 1993 Gastroenterol. Clin. North Am. pmid:7685324
Ahmed SS et al. Adrenochrome reaction implicates oxygen radicals in metabolism of cyclosporine A and FK-506 in rat and human liver microsomes. 1993 J. Pharmacol. Exp. Ther. pmid:7685382
Sewell KL Immunotherapy and other novel therapies, including biologic response modifiers, apheresis, and dietary modifications. 1993 Curr Opin Rheumatol pmid:7685614
Wagner JA et al. Failure of FK 506 to suppress the T cell-mediated immunity of mice to Listeria monocytogenes. 1993 Clin. Exp. Immunol. pmid:7685672
Pilot-Matias TJ et al. High-level synthesis of the 12-kDa human FK506-binding protein in Escherichia coli using translational coupling. 1993 Gene pmid:7685727
Akamine S et al. [Effect of FK-506 on bronchial healing of canine lung allografts]. 1993 Nihon Kyobu Geka Gakkai Zasshi pmid:7685803
Partaledis JA and Berlin V The FKB2 gene of Saccharomyces cerevisiae, encoding the immunosuppressant-binding protein FKBP-13, is regulated in response to accumulation of unfolded proteins in the endoplasmic reticulum. 1993 Proc. Natl. Acad. Sci. U.S.A. pmid:7685904
Sykes K et al. Proline isomerases function during heat shock. 1993 Proc. Natl. Acad. Sci. U.S.A. pmid:7685914
Henke W and Jung K Comparison of the effects of the immunosuppressive agents FK 506 and cyclosporin A on rat kidney mitochondria. 1993 Biochem. Pharmacol. pmid:7690566
Murase N et al. Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs. 1993 Transplantation pmid:7682735
Emond JC et al. Improved results of living-related liver transplantation with routine application in a pediatric program. 1993 Transplantation pmid:7682738
Kai N et al. Prevention of insulitis and diabetes in nonobese diabetic mice by administration of FK506. 1993 Transplantation pmid:7682740
Altmeyer A and Dumont FJ Rapamycin inhibits IL-1-mediated interferon-gamma production in the YAC-1 T cell lymphoma. 1993 Cytokine pmid:7687472
Przepiorka D et al. Bronchiolitis obliterans organizing pneumonia in a BMT patient receiving FK506. 1993 Bone Marrow Transplant. pmid:7687503
Bram RJ et al. Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location. 1993 Mol. Cell. Biol. pmid:7687744
Heitman J et al. The immunosuppressant FK506 inhibits amino acid import in Saccharomyces cerevisiae. 1993 Mol. Cell. Biol. pmid:7687745
Abu-Elmagd K et al. Recent advances in hepatic transplantation at the University of Pittsburgh. 1993 Clin Transpl pmid:7522528
Hirakawa K et al. [The effect of perioperative portal venous inoculation with donor lymphocytes in combination with immunosuppressive agents on rat cardiac allograft survivals]. 1993 Nihon Geka Gakkai Zasshi pmid:7688065
Entani C et al. Effect of a novel immunosuppressant, FK506, on spontaneous lupus nephritis in MRL/MpJ-lpr/lpr mice. 1993 Nephron pmid:7688103
Ueki M et al. Diabetogenic effects of FK506 on renal subcapsular islet isografts in rat. 1993 Diabetes Res. Clin. Pract. pmid:7688276
Pleyer U et al. Ocular absorption of topically applied FK506 from liposomal and oil formulations in the rabbit eye. 1993 Invest. Ophthalmol. Vis. Sci. pmid:7688360
Machida M [Effect of temperature on plasma concentration of FK506]. 1993 Nippon Hinyokika Gakkai Zasshi pmid:7688443
Ohzato H et al. Serum interleukin-6 levels as an indicator of acute rejection after liver transplantation in cynomologous monkeys. 1993 Surg. Today pmid:7689373
Fesik SW NMR structure-based drug design. 1993 J. Biomol. NMR pmid:7689377
McManus BM et al. Direct myocardial injury by enterovirus: a central role in the evolution of murine myocarditis. 1993 Clin. Immunol. Immunopathol. pmid:7689428
Namiki Y et al. Tautomeric phenomenon of a novel potent immunosuppressant (FK506) in solution. I. Isolation and structure determination of tautomeric compounds. 1993 J. Antibiot. pmid:7689551
Kondo T et al. [Antitumor sensitivity test, subrenal capsule assay using FK-506: preliminary report]. 1993 Nihon Geka Gakkai Zasshi pmid:7689693
Abu-Elmagd K et al. Resolution of severe pyoderma gangrenosum in a patient with streaking leukocyte factor disease after treatment with tacrolimus (FK 506). 1993 Ann. Intern. Med. pmid:7689802
Christensen BG FK-506: its role in immunosuppression. 1993 Ann. N. Y. Acad. Sci. pmid:7689803
Kino T and Goto T Discovery of FK-506 and update. 1993 Ann. N. Y. Acad. Sci. pmid:7689804
Parsons WH et al. FK-506--a novel immunosuppressant. 1993 Ann. N. Y. Acad. Sci. pmid:7689805
Zenke G et al. Molecular mechanisms of immunosuppression by cyclosporins. 1993 Ann. N. Y. Acad. Sci. pmid:7689806
Hirai T et al. Prolonged lung allograft survival with a short course of FK 506. 1993 J. Thorac. Cardiovasc. Surg. pmid:7678313
Ibarra F et al. Bidirectional regulation of Na+,K(+)-ATPase activity by dopamine and an alpha-adrenergic agonist. 1993 Proc. Natl. Acad. Sci. U.S.A. pmid:7678337
Murase N et al. Graft-versus-host disease after brown Norway-to-Lewis and Lewis-to-Brown Norway rat intestinal transplantation under FK506. 1993 Transplantation pmid:7678353
Herold KC et al. Inhibition of glucose-stimulated insulin release from beta TC3 cells and rodent islets by an analog of FK506. 1993 Transplantation pmid:7678356
Holman MJ et al. FK506-associated thrombotic thrombocytopenic purpura. 1993 Transplantation pmid:7678357
Kawai M et al. Structure-activity profiles of macrolactam immunosuppressant FK-506 analogues. 1993 FEBS Lett. pmid:7678400
Van Duyne GD et al. Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin. 1993 J. Mol. Biol. pmid:7678431
Meadows RP et al. Three-dimensional structure of the FK506 binding protein/ascomycin complex in solution by heteronuclear three- and four-dimensional NMR. 1993 Biochemistry pmid:7678499
Jiang H et al. Anti-tumor-promoting action of FK506, a potent immunosuppressive agent. 1993 Carcinogenesis pmid:7678785
Naito M et al. Enhancement of cellular accumulation of cyclosporine by anti-P-glycoprotein monoclonal antibody MRK-16 and synergistic modulation of multidrug resistance. 1993 J. Natl. Cancer Inst. pmid:7678867
Hirasé Y et al. Transplantation of long-term cryopreserved allocutaneous tissue by skin graft or microsurgical anastomosis: experimental studies in the rat. 1993 Plast. Reconstr. Surg. pmid:7679796